EUVIMEDEUVIMED entdecken
Crossref

Three‐Month Posttransplant Lipidomic Profile Reflects Acute GVHD but Not Chronic GVHD Risk in Allogeneic Stem Cell Recipients

Tor Henrik Anderson Tvedt, Christian Qvigstad, Katerina Nezvalova-Henriksen, Birgitte S Bergland, Øystein Bruserud, Håkon Reikvam iD

European Journal of Haematology · 2025

DOI: 10.1111/ejh.70011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2025. Verfasst von Tor Henrik Anderson Tvedt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Lipidomics. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Helse Vest, Family Blix fund, Rotary International.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Graft‐versus‐host disease (GVHD) is the most prevalent long‐term complication following allogeneic hematopoietic stem cell transplant (allo‐HSCT). This study aimed to investigate specific posttransplant metabolic alterations in allo‐HSCT recipients with acute myelogenous leukemia (AML) or myelodysplastic neoplasms (MDS).

Methods

We analyzed the global metabolic profile in serum samples from 37 patients at 3 months posttransplantation. Among these patients, 25 later developed chronic GVHD (cGVHD), and nine of these 25 patients had previously experienced acute GVHD (aGVHD).

Results

Principal component and hierarchical cluster analyses revealed distinct metabolic clusters associated with GVHD. Random forest analysis confirmed the distinct metabolic profile for aGVHD, with an out‐of‐bag accuracy of 92%. Patients with previous aGVHD exhibited elevated levels of sphingamines and bile acids, and reduced levels of corticosteroids and lysophosphatidylethanolamines. Notably, lysophosphatidic acids (LPAs) such as LPA 22:4, LPA 20:0, and LPA 16:0 were significantly lower in aGVHD patients, indicating potential disruption in LPA‐mediated signaling. In contrast, no significant metabolic differences were associated with later development of cGVHD. The lack of distinct metabolic markers for cGVHD suggests that the disease's chronic nature might involve more complex and multifaceted mechanisms beyond serum metabolic alterations.

Conclusion

Our findings indicate that aGVHD and cGVHD differ in their lipidomic profiles, with only partial overlap. This further underscores the potential of metabolomic profiling to identify biomarkers for aGVHD, while highlighting the need for larger, multicenter studies and longitudinal analyses to better understand the metabolic underpinnings of cGVHD and improve clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationLipidomicsHumansMaleFemaleMiddle AgedAdultTransplantation, HomologousBiomarkersChronic DiseaseAgedAcute DiseaseYoung AdultLeukemia, Myeloid, Acute

Stichwörter der Autor:innen

allogenic stem cell transplantationgraft‐versus‐host diseaselipidomicsmetabolomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Haematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
  • K.G. Jebsen Center for Myeloid Malignancies, Department of Clinical Science, University of Bergen, Bergen, Norway.

ORCID-Profile: Håkon Reikvam

Förderung

  • Helse Vest
  • Family Blix fund
  • Rotary International
  • Rakel and Otto Kristian Bruun's fund
  • Øyvinn Mølbach-Pedersens fund

Zitieren

APA

Tvedt, T. H. A., Qvigstad, C., Nezvalova-Henriksen, K., Bergland, B. S., Bruserud, Ø., & Reikvam, H. (2025). Three‐Month Posttransplant Lipidomic Profile Reflects Acute GVHD but Not Chronic GVHD Risk in Allogeneic Stem Cell Recipients. European Journal of Haematology. https://doi.org/10.1111/ejh.70011

Vancouver

Tvedt THA, Qvigstad C, Nezvalova-Henriksen K, Bergland BS, Bruserud Ø, Reikvam H. Three‐Month Posttransplant Lipidomic Profile Reflects Acute GVHD but Not Chronic GVHD Risk in Allogeneic Stem Cell Recipients. European Journal of Haematology. 2025. doi:10.1111/ejh.70011

BibTeX
@article{Tvedt2025,
  author = {Tvedt, Tor Henrik Anderson and Qvigstad, Christian and Nezvalova-Henriksen, Katerina and Bergland, Birgitte S and Bruserud, Øystein and Reikvam, Håkon},
  title = {Three‐Month Posttransplant Lipidomic Profile Reflects Acute GVHD but Not Chronic GVHD Risk in Allogeneic Stem Cell Recipients},
  journal = {European Journal of Haematology},
  year = {2025},
  doi = {10.1111/ejh.70011}
}
Kostenlos starten →